Literature DB >> 24948689

Uveitis as a prognostic factor in multiple sclerosis.

Erkingul Shugaiv1, Erdem Tüzün2, Murat Kürtüncü1, Aslı Kıyat-Atamer3, Arzu Çoban1, Gulsen Akman-Demir3, Ilknur Tugal-Tutkun1, Mefkure Eraksoy1.   

Abstract

Uveitis is occasionally encountered in multiple sclerosis (MS) patients. The objective of this report is to investigate whether uveitis has a prognostic impact on the clinical course of MS. Several clinical and demographic features were compared between 41 MS patients with uveitis and 100 randomly selected MS patients without uveitis. While there were no significant differences by means of gender, age of MS onset, oligoclonal band positivity and disease duration, EDSS and progression index (PI) scores of MS patients with uveitis were significantly lower than those without uveitis (p = 0.004 and <0.001, respectively). Our results suggest that uveitis might be used as a good prognostic factor.
© The Author(s), 2015.

Entities:  

Keywords:  EDSS; Multiple sclerosis; autoimmunity; disability; uveitis

Mesh:

Year:  2014        PMID: 24948689     DOI: 10.1177/1352458514539782

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Multiple Sclerosis and Panuveitis: A Rare Association.

Authors:  Burcu Gökçe Çokal; H Nalan Güneş; Selda Keskin Güler; Tahir Kurtuluş Yoldaş; Caner Baydar; Sevim Kavuncu
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

2.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

3.  Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.

Authors:  Eyal Raskin; Anat Achiron; Ofira Zloto; Ron Neuman; Vicktoria Vishnevskia-Dai
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

Review 4.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

5.  Recommendations for observational studies of comorbidity in multiple sclerosis.

Authors:  Ruth Ann Marrie; Aaron Miller; Maria Pia Sormani; Alan Thompson; Emmanuelle Waubant; Maria Trojano; Paul O'Connor; Kirsten Fiest; Nadia Reider; Stephen Reingold; Jeffrey A Cohen
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910

6.  Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.

Authors:  D Coric; G Ometto; G Montesano; P A Keane; L J Balk; B M J Uitdehaag; A Petzold; D P Crabb; A K Denniston
Journal:  Eur J Neurol       Date:  2019-08-18       Impact factor: 6.089

7.  Clinical and Radiological Characteristics of Children and Adults With First-Attack Myelin Oligodendrocyte Glycoprotein Antibody Disease and Analysis of Risk Factors for Predicting the Severity at Disease Onset in Central China.

Authors:  Yanfei Li; Haojie Xie; Jinwei Zhang; Yongyan Zhou; Lijun Jing; Yaobing Yao; Ranran Duan; Yanjie Jia
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.